• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Catalog Number 9-ASD-009
Medical Device Problem Code Difficult to Fold, Unfold or Collapse (1254)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/26/2024
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that on (b)(6) 2024, a 9mm amplatzer septal occluder was chosen for implant using a 7f amplatzer trevisio intravascular delivery system.During procedure, when the physician tried to deploy the device at left atrial into right atrial then the deice deformed into a cobra shape.The physician took the device out and prepared again, but during deployment the device again deformed into cobra shape.The deformed device was never released from the delivery cable while inside the patient.A new 9mm amplatzer septal occluder was chosen, but during deployment the device deformed into a cobra shape.The deformed device was never released from the delivery cable while inside the patient.There was no report of any interaction with cardiac structures during deployment and no report of any angulation/kink noticed with the delivery system.The physician changed the device into a new 10mm amplatzer septal occluder and deployed successfully.The patient remained hemodynamically stable throughout the procedure.There was no clinically significant delay in procedure and no adverse patient effects.The patient was reported stable.
 
Additional Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Additional Manufacturer Narrative
An event of device deformity did not be confirmed.The device was returned to abbott for investigation and the device met functional specifications when analyzed under non-physiological conditions.Additionally, a images were received from the field and it appeared to show the device deformity.However, it could not be confirmed as there was no deformity during the returned device analysis.Reportedly, a 7f delivery system was used.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.The cause of the reported incident could not be conclusively determined.It is possible due to a large size delivery system could have contributed to the reported event.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
 
Event or Problem Description
It was reported that on (b)(6) 2024, a 9mm amplatzer septal occluder was chosen for implant using a 7f amplatzer trevisio intravascular delivery system.During procedure, when the physician tried to deploy the device at left atrial into right atrial then the deice deformed into a cobra shape.The physician took the device out and prepared again, but during deployment the device again deformed into cobra shape.The deformed device was never released from the delivery cable while inside the patient.A new 9mm amplatzer septal occluder was chosen, but during deployment the device deformed into a cobra shape.The deformed device was never released from the delivery cable while inside the patient.There was no report of any interaction with cardiac structures during deployment and no report of any angulation/kink noticed with the delivery system.The physician changed the device into a new 10mm amplatzer septal occluder and deployed successfully.The patient remained hemodynamically stable throughout the procedure.There was no clinically significant delay in procedure and no adverse patient effects.The patient was reported stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Common Device Name
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key19145261
Report Number2135147-2024-01775
Device Sequence Number15412387
Product Code MLV
UDI-Device Identifier00811806010069
UDI-Public(01)00811806010069(17)271231(10)8864630
Combination Product (Y/N)N
Initial Reporter CountryTW
PMA/510(K) Number
P000039
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Device Explanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number9-ASD-009
Device Lot Number8864630
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer Not provided
Supplement Date Received by Manufacturer05/02/2024
Initial Report FDA Received Date04/19/2024
Supplement Report FDA Received Date05/22/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/30/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
AMPLATZER SEPTAL OCCLUDER, 9-ASD-009, LOT 8200504; AMPLATZER TREVISIO INTRAVASCULAR DS, 9-ATV07F45/8
Patient Age24 MO
Patient SexFemale
-
-